Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy

Ethlinn V B van Gaal1, Wim E Hennink, Daan J A Crommelin

  • 1Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O Box 80082, 3508 TB, Utrecht, The Netherlands.

Summary

Optimizing gene therapy involves enhancing transgene expression. This review explores strategies for efficient, controlled, and long-term genetic material delivery for improved therapeutic outcomes.